This insider is sharing a firsthand account of cannabis sales during the coronavirus…

Editor’s Note: Yesterday’s first-ever virtual NICI Town Hall was a huge success. Executive Director Don Yocham was there for you, answering dozens of live member questions about the current market, the best stocks to buy during the coronavirus, and so much more. Several of our readers even had the chance to talk to Don directly – and you can watch it all for free right here.

It always helps to have boots on the ground.

Someone right in the middle of the action.

Having that inside connection gives you an edge.

It lets you identify popular trends before anyone else. In turn, you can utilize that knowledge to invest in the companies that are capitalizing on shifts in customer preferences. Or you can sell off the laggards who can’t (or won’t) meet the new demand.

That’s why I wanted to introduce you to my friend, Charlie Delvalle.

As an entrepreneur and the co-founder of a cannabis brand in Oregon, he has a firsthand account of what dispensary owners are experiencing during this period of uncertainty.

He knows what customers are asking because they talk to him directly. He knows what they were stockpiling as the coronavirus was first spreading because he saw what was flying off the shelves.

And with everything that’s going on, I wanted to make sure Charlie sent out this report to you as soon as possible…

Charlie’s Report From the Field

Before I share Charlie’s expert insight, I wanted to add some more color to his background.

He’s a value investor, so he knows how to be patient and wait for a good deal.

On the cannabis side, he is the co-founder of Hashstoria, and he’s set to open three new retail storefronts this year. One will be in Portland, and another will be in Oklahoma City, Oklahoma.

Because of his unique viewpoint, I asked Charlie if he could share more about what he’s seeing during the coronavirus.

Now, the one thing to know about Charlie is that he’s a straight shooter. He’s going to tell it like it is.

And in his report, he doesn’t hold back.

Charlotte’s Web just made a major acquisition that solidified its status as one of the largest CBD companies in North America. Find out what this means for you.

The coronavirus has sped up what we’ve referred to as “Phase 2” for the cannabis industry. That’s when the winners separate themselves from the wannabes.

The winners will be able to scoop up valuable assets – equipment, brands, tech, and even skilled employees – from failed companies, and you’ll also see a lot more merger and acquisition (M&A) activity.

And that’s exactly what Charlie says is happening.

Charlie told me that, “Ultimately, many of these players are going to end up selling their business to people like me.”

Everything he shares in his new report should be at the top of your reading list for today. He talks about cannabis sales, the types of companies that will come out of the coronavirus pandemic even stronger than before, and what company is at the top of his watch list as a value play.

It’s all in this report.

Take care,

Don Yocham, CFA

Executive Director, National Institute for Cannabis Investors

P.S. You’re invited to join my good friend Neil Patel and I in the Angels & Entrepreneurs Private Dealroom for an exclusive meeting with one of the most prestigious doctors in the world. His startup just finalized a medical device that could completely revolutionize a $19 billion industry. If it gets FDA approval, it can impact millions of Americans every year. The deal has already passed the 1,000X Formula, meaning the profit potential here can be exponential. But time is ticking… this is a very rare deal opportunity that closes at midnight on April 24. Click here to claim your seat now.


6 responses to “An Inside Look at Cannabis Sales During the Coronavirus”

  1. Just read a report downplaying CWBHF. I have held this for over a year now and I’m really losing in this stock. The report said this stock would likely go to zero. I don’t know if I should sell out now or keep holding on. Any advice?

    • Hi Agatha,

      If you are looking to buy Trulieve, shares currently trade at $9.32, so you can buy as little or as many shares as you would like.

      To start you will need to open a brokerage account. The National Institute for Cannabis Investors does not buy or sell stocks for our members.

      These are some of the brokerages our members use and their customer service numbers are included to help you get started:
      eTrade 1 (800) 387-2331
      Fidelity – 1 (800) 343-3548
      TDAmeritrade – 1 (800) 669-3900

Leave a Reply

Your email address will not be published. Required fields are marked *